Lifeway Foods Inc logo

Lifeway Foods Inc(LWAY)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$21.72
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for LWAY

11/13/2026: LWAY (1-star) is currently NOT-A-BUY. Pass it for now.

Lifeway Foods Inc is a consumer packaged goods company recognized for manufacturing drinkable kefir and probiotic health foods. The company maintains a leading position in the U.S. kefir category, backed by a debt-free balance sheet and steady revenue growth. Its primary growth story centers on expanding mainstream retail distribution and scaling newer plant-based product lines. Key risks include intense competition from much larger food conglomerates and exposure to agricultural input cost inflation. The stock suits growth-oriented investors willing to tolerate micro-cap liquidity while monitoring distribution expansion and raw material cost trends.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fit while signal remains positiveLifeway offers compelling revenue growth off a small market base driven by expanding consumer demand for functional probiotic foods.
Momentum investorStrong fit while signal remains positiveMomentum fit is conditional on a positive Upturn signal reflecting strong recent stock price appreciation and breakout volume.
Value investorMixed fitValuation levels can fluctuate based on recent earnings rallies, though its clean asset base provides fundamental support.
Dividend investorWeak fitLifeway does not pay a regular dividend, prioritizing capital reinvestment over income distribution.
Low-risk investorMixed fitMicro-cap stock liquidity and potential earnings volatility offset the benefit of the company's clean, low-debt balance sheet.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighAs a micro-cap equity, the stock experiences sharp price swings driven by lower trading volumes.
Valuation riskMedium / highRapid rallies in share price can stretch valuation multiples relative to near-term earnings growth.
Competition risk (Danone and mainstream dairy giants)HighLarger food conglomerates possess vastly superior capital resources to challenge shelf-space dominance.
Business qualityMedium / highThe company maintains solid gross margins and a debt-free balance sheet, though product concentration remains a constraint.
Dividend incomeLow / noneIncome-focused investors will find no meaningful dividend distributions.
Execution riskMediumManagement must successfully scale distribution and manage agricultural input cost inflation to protect profitability.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 328.15M USD
Price to earnings Ratio 45.25
1Y Target Price 32.33
Price to earnings Ratio 45.25
1Y Target Price 32.33
Volume (30-day avg) 124.9K shares
Beta 0.49
52 Weeks Range 17.31 - 32.71
Updated Date 11/15/2026
52 Weeks Range 17.31 - 32.71
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.48

Sector & Industry Intelligence

Sector

Consumer Defensive

Defensive
Sentiment
Correction Expected
Momentum
BUY Breadth Improving
BUY participation
95.0%
Active BUY / eligible
19 / 20
30-Day BUY Count Change
+13
Market state
Correction Expected

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Industry classification is unavailable for this snapshot.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Rolling Over
PRICE PATH

Rolling Over

The price momentum is slowing down and beginning to turn downward.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit -20.94%
Avg. Invested days 38
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
LWAY receives a 3-star rating, supported by solid analyst coverage. The rating is constrained by soft unit economics, and weak price momentum.

Company Fundamentals

★★★★★
LWAY has moderate overall fundamentals (3 stars), with moderate financial health, moderate growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+53.6%) and solid revenue growth (+13.7%) are partially offset by weak cash generation (FCF margin -7.7%), soft profitability (net margin 6.5%).

Financial Health Rating

★★★★★
LWAY's financial health is supported by moderate liquidity, including working-capital and asset support (WC/assets 19.3%). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is LWAY's strongest growth driver at +53.6% FY2025 versus FY2024 (strong, 5 stars). By comparison, revenue growth (+13.7%, solid) is also solid, while free-cash-flow growth (-362.0%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 58.1% and approximately 43.0% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 39.40% supports management-shareholder alignment.

Top 5 Institutional Investors

Divisadero Street Capital Management, LP 13.91%
Citadel Advisors Llc 6.16%
Wellington Management Company LLP 3.87%
Vanguard Capital Management, LLC 2.43%
Renaissance Technologies Corp 2.31%

Unit Economics (Per $1K Revenue)

★★★★★
LWAY generates approximately $274 of gross profit, $76 of operating income, and $-77 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Negative free cash flow explains the 2-star rating, with weak cash conversion and solid capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 29.60%

Quantitative Style Profile

★★★★★
LWAY has a relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilitySmall / Mid Cap RiskShort Squeeze Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
Drinkable Kefir ProductsFlagship organic and conventional probiotic dairy kefir beverages sold across retail grocery channels.This is the primary engine driving the vast majority of Lifeway's total revenues and brand recognition.
Specialty Cultured Dairy & Plant-Based LineFarmer cheese, cream spreads, ProBugs kids items, and oat-milk based probiotic alternatives.These secondary product categories diversify revenue streams into adjacent health-food trends.

Earnings Date

Report Date 2026-11-12
When After Market
Estimate 0.05
Actual 0.02

Profitability

Profit Margin 3%
Operating Margin (TTM) 4.65%

Management Effectiveness

Return on Assets (TTM) 6.08%
Return on Equity (TTM) 9.04%

Valuation

Trailing PE 45.25
Forward PE 29.94
Enterprise Value 345.53M
Price to Sales(TTM) 1.3
Enterprise Value 345.53M
Price to Sales(TTM) 1.3
Enterprise Value to Revenue 1.37
Enterprise Value to EBITDA 21.35
Shares Outstanding 15.11M
Shares Floating 6.49M
Shares Outstanding 15.11M
Shares Floating 6.49M
Percent Insiders 39.4
Percent Institutions 58.11

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.